Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;35(1):78-87.
doi: 10.1111/pcmr.13007. Epub 2021 Aug 12.

The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma

Affiliations

The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma

Vivian Chua et al. Pigment Cell Melanoma Res. 2022 Jan.

Abstract

Metastatic uveal melanoma (UM) responds poorly to targeted therapies and immune checkpoint inhibitors. Loss of BRCA1-associated protein 1 (BAP1) via inactivating mutations in the BAP1 gene is associated with UM progression. Thus, molecular alterations caused by BAP1 dysfunction may be novel therapeutic targets for metastatic UM. Here, we found that phosphorylation of AMP-dependent kinase (AMPK) was elevated in BAP1-altered (or mutant) compared to BAP1-unaltered (or wild-type [WT]) UM tumors. As a readout of AMPK pathway activation, phosphorylation of an AMPK downstream effector, acetyl-CoA-carboxylase (ACC), was also elevated. BAP1 re-expression in BAP1-null UM cell lines decreased phospho-AMPK (pAMPK) and phospho-ACC (pACC) levels. AMPK phosphorylation is mediated by calcium/calmodulin dependent protein kinase kinase 2 (CaMKK2) and potentially liver kinase B1 (LKB1) in BAP1 mutant UM cells. Knockdown of AMPKα1/2 reduced the viability of BAP1 mutant UM cells, indicating a survival function of AMPK in BAP1 mutant UM. Our data suggest that the AMPK pathway is an important mechanism mediating the survival of BAP1 mutant UM. Targeting the AMPK pathway may be a novel therapeutic strategy for metastatic UM.

Keywords: AMPK; BAP1; stress; uveal melanoma.

PubMed Disclaimer

References

REFERENCES

    1. Amirouchene-Angelozzi, N., Nemati, F., Gentien, D., Nicolas, A., Dumont, A., Carita, G., Camonis, J., Desjardins, L., Cassoux, N., Piperno-Neumann, S., Mariani, P., Sastre, X., Decaudin, D., & Roman-Roman, S. (2014). Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target. Mol Oncol, 8(8), 1508-1520. https://doi.org/10.1016/j.molonc.2014.06.004
    1. Bononi, A., Giorgi, C., Patergnani, S., Larson, D., Verbruggen, K., Tanji, M., & Carbone, M. (2017). BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation. Nature, 546(7659), 549-553.
    1. Bononi, A., Yang, H., Giorgi, C., Patergnani, S., Pellegrini, L., Su, M., Xie, G., Signorato, V., Pastorino, S., Morris, P., Sakamoto, G., Kuchay, S., Gaudino, G., Pass, H. I., Napolitano, A., Pinton, P., Jia, W., & Carbone, M. (2017). Germline BAP1 mutations induce a Warburg effect. Cell Death and Differentiation, 24(10), 1694-1704. https://doi.org/10.1038/cdd.2017.95
    1. Carbone, M., Harbour, J. W., Brugarolas, J., Bononi, A., Pagano, I., Dey, A., & Gaudino, G. (2020). Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discovery, 10(8), 1103-1120.
    1. Chattopadhyay, C., Oba, J., Roszik, J., Marszalek, J. R., Chen, K., Qi, Y., Eterovic, K., Robertson, A. G., Burks, J. K., McCannel, T. A., Grimm, E. A., & Woodman, S. E. (2019). Elevated endogenous SDHA drives pathological metabolism in highly metastatic uveal melanoma. Investigative Ophthalmology & Visual Science, 60(13), 4187-4195. https://doi.org/10.1167/iovs.19-28082

Publication types

MeSH terms

Substances

LinkOut - more resources